August 24, 2021

Company Name:
Optorun Co., Ltd.
Name of Representative: Ihei Hayashi
Representative Director and President/CEO(Securities Code: 6235 Tokyo Stock Exchange Section 1)
Inquiries:
Mitsuo Yamada
Director and Executive Officer
Corporate Management Department(TEL: +81-3-6635-9487)

Announcement of earnings forecast revisionThis is to inform you that, based on recent business trends, the Board of Directors have decided to revise
Optorun’s earnings forecast for the fiscal year ending December 2021, which were originally announced onFebruary 12, 2021, as follows.
1.Revision of Performance Forecast
Revision of Consolidated Forecast for Business Results for Fiscal Year Ended December 31, 2021 (January 1,2021 to December 31, 2021)
OperatingO r d i n ar yProfit attributable toNet income

i n c o m e

i n c o m e

ow ne r s o f p a ren t

Per share

Millions of yen

Millions of yen

Millions of yen

Millions of yen

Yen

Previous forecast (A)38,100

9,000

9,000

7,000

162.90

Rev ised forecast (B)30,300

6,800

7,100

5,600

130.02

Ch ang e( B-A)

△7,800△2,200△1,900△1,400-C h a n g e( % )

△20.5

△24.4

△21.1

△20.0-

37,491

8,628

8,609

6,796

159.05

Netsales(Reference)
Consolidated results forthe previous fiscal year
FY12/19(Reason for amendment)
Amid the global shortage of semiconductors and the Covid-19 pandemic situation continuing to have animpact on the global macro economy, our customers' demand for capital investment is lower than originally
anticipated, and our equipment sales are forecast to decline below expectations. In the future, smartphones,mini-LEDs, and automobile applications, among others, are likely to play leading roles for the recovery of thedemand for these equipments. However, this will depend on the normalization of semiconductor supply andCovid-19 containment.
In line with the downward revision of net sales, we decided to further enhance the efficiency of our SG&A
expenses. We reviewed all SG&A expenses budgets, except for R&D expenses, and decided to reduce
expenses by approximately 10% from the initial budget at all domestic and overseas sites through the rest offiscal 2021.
As far as our new-type equipment product is concerned, to date, we have achieved a ratio exceeding the targetof 30% of net sales set at the beginning of this year. We are working to expand sales of new-type equipment,
including but not limited to ALD equipment and horizontal sputtering equipment, which are expected to makea substantial contribution to improving the overall cost-of-sales ratio.
Research and development expenses will be maintained at the initial budget of 3.1 billion yen. As an R&Ddriven company, we continue to develop new equipment that reflects our advanced deposition technology forthe global market. We have positioned 2021 as a year for further sophisticating optical thin-film technology
and developing new optical thin-film deposition technology for semiconductor-related applications, andcontinue to accelerate the pace of R&D. These R&D activities are expected bear results in the future
developments of deposition equipment for mini-LED, automobile application, high-end smartphone-related
3D technology, 5G optical communication networks, and biosensor development in the healthcare field.
We maintain the forecast for the year-end dividend at 50 yen per share.